Vaxart’s headquarters is located at:
170 Harbor Way, Suite 300
South San Francisco, CA 94080
Telephone: (650) 550-3500
Shares of Vaxart trade on the Nasdaq Capital Market under the symbol VXRT.
Vaxart does not offer a direct investment program. To purchase shares of VXRT, please contact a registered broker.
Vaxart’s fiscal year end is December 31.
Vaxart does not currently pay dividends.
Vaxart reports financial results on a quarterly basis. For our upcoming earnings announcements and other investor events, please see our Events & Presentations page and most recent press releases.
Vaxart’s independent auditor is Withum Smith+Brown, PC.
Vaxart’s transfer agent is:
American Stock Transfer & Trust Company, LLC
6201 15th Ave.
Brooklyn, NY 11219
Telephone: (800) 937-5449 or (718) 921-8124
Email: helpast@equiniti.com
For questions concerning stock holdings, certificate replacement/transfer, and address changes, please contact our transfer agent:
American Stock Transfer & Trust Company, LLC
6201 15th Ave., Brooklyn, NY 11219
(800) 937-5449 or (718) 921-8124
Email: help@astfinancial.com
For questions concerning former Biota stock holdings, certificate replacement/transfer, and address changes, please contact our transfer agent:
American Stock Transfer & Trust Company, LLC
6201 15th Ave., Brooklyn, NY 11219
(800) 937-5449 or (718) 921-8124
Email: help@astfinancial.com
Annual 10-K reports, quarterly 10-Q reports, proxy statements and other filings with the SEC can be accessed directly through the SEC filings section of Vaxart’s website or through the Securities and Exchange Commission at www.SEC.gov.
For more information on career opportunities at Vaxart, please visit the Careers section of our website.
For more information on trial participation, please send an inquiry to info@vaxart.com, and the appropriate party will respond to your request.
For information on Vaxart’s clinical trials, please see our most recent press releases.